Securing comparator drugs in the EU is a complex process shaped by availability constraints, regulatory expectations, and competitive market behavior. But if we have the right planning, strong ...

Junejo talked through some of the ways UKGI is using AI. Its project management function is AI, but also digitally-enabled to ...

In today’s ACT Brief, we examine the growing challenges of sourcing comparator drugs across the EU, highlight a new AI-driven ...

Patients with autoimmune hepatitis have no increased long-term risk for psychiatric disorders compared with the general population.

CG Oncology develops cretostimogene via rolling BLA, phase 3 PIVOT-006 data in 1H 2026, and $680M cash into 2028. Find out ...

Immuneering Corporation stays a Strong Buy: pancreatic cancer combo shows 64% 12‑mo OS, strong safety, and clear catalysts ...

Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product ...

Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene delivery, today announced Dyno-yp2, a novel adeno-associated ...

Palmer brings claims under the Age Discrimination in Employment Act and for wrongful termination in violation of North ...

Newly diagnosed patients with KRAS G12C-mutant advanced or metastatic nonsquamous NSCLC will be enrolled in the trial.

Using a single microcontroller port to drive a multi-digit LED display to help engineers with those last-minute design ...

A Type B meeting between the FDA and Plus Therapeutics offered clarity and direction for the next steps in development of ...